Investigative Site #109 — Philadelphia, Pennsylvania

Investigative Site #109 is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Investigative Site #109 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumor, Prostate Cancer.

Sponsors: MOMA Therapeutics.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site #109?

Investigative Site #109 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site #109 conducted?

Investigative Site #109 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Metastatic Solid Tumor, Prostate Cancer.

Is Investigative Site #109 accredited by Crixeo Health?

Investigative Site #109 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site #109?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.